Future doc, I also do not know if cancer cells would be in the blood stream for early cancers but I did read where the test could capture a single cell. The odds of a single cell "anchoring" anywhere may be low but I would think it is likely that any cancer of early stage would shed come cells into the blood stream.
Answer this. Do you think JNJ would pay $51 million for a test that would only detect late stage cancer? About as likely as a snowball in hell.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.